Civica Rx and Kaiser, two non-profit organizations, have announced a partnership to ensure the uninterrupted supply of essential generics to health providers across US during the coronavirus pandemic.
Civica Rx has announced a partnership with Kaiser Permanente to improve the availability and affordability of essential generics for health providers, particularly those medications which are being used in the treatment of COVID-19.
While Civica is already delivering 20 essential generics – 10 of which are currently being used to treat COVID-19 patients...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
